• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Persistence of the 2009 Pandemic Influenza A (H1N1) Virus (pH1N1) on N95 Respirators

tetano

Editor, Senior Moderator
Appl Environ Microbiol. 2013 Jan 18. [Epub ahead of print]
Persistence of the 2009 Pandemic Influenza A (H1N1) Virus (pH1N1) on N95 Respirators.
Coulliette AD, Perry KA, Edwards J, Noble-Wang J.
Source

National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control, Atlanta, GA 30307.
Abstract

In the U.S., the 2009 pandemic influenza A (H1N1) virus (pH1N1) infected almost 20% of the population and caused >200,000 hospitalizations and >10,000 deaths during April 2009 to April 2010. On April 24, 2009, CDC posted interim guidance on infection control measures in healthcare settings specifically for pH1N1, which recommended filtering face respirators (FFRs) when in close contact with a suspected/confirmed infected individual and particularly when performing aerosol procedures. The persistence and infectivity of pH1N1 was evaluated on FFRs, specifically N95 respirators, under varying conditions of absolute humidity (AH; 4.1 millibar (mb), 6.5 mb, and 14.6 mb), sample matrices (2% fetal bovine serum (FBS), 5 mg/ml mucin, and viral media), and time (4, 12, 24, 48, 72, and 144 hours). pH1N1 was distributed onto N95 coupons (3.8 to 4.2 cm(2)), extracted by a vortex/centrifugation/filtration process, and the ability of remaining virus to replicate was quantified by ELISA to determine the log(10) concentration of infectious virus per coupon. Overall, pH1N1 remained infectious for 6 days with approximately 1 log(10) loss of viral concentrations over this time period. Time and AH both affected viral survival. We found significantly higher (p ≤0.01) reductions in virus concentrations at time-points beyond 24 to 72 hours (-0.52 log(10) reduction) and 144 hours (-0.74) at AHs of 6.5 mb (-0.53) and 14.6 mb (-0.47). This research supports the discarding of respirators after close contact with a person with suspected or confirmed influenza infection due to the virus's demonstrated ability to persist and remain infectious.

PMID:
23335770
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23335770
 
Back
Top